Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78,365,632
-
Total 13F shares
-
17,921,621
-
Share change
-
+15,082,653
-
Total reported value
-
$288,535,000
-
Price per share
-
$16.10
-
Number of holders
-
52
-
Value change
-
+$242,828,175
-
Number of buys
-
51
Institutional Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q3 2018
As of 30 Sep 2018,
Replimune Group, Inc. - COMMON STOCK (REPL) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,921,621 shares.
The largest 10 holders included
Omega Fund Management, LLC, Bain Capital Life Sciences Investors, LLC, Redmile Group, LLC, Foresite Capital Management IV, LLC, BVF INC/IL, Foresite Capital Management III, LLC, EMERALD ADVISERS INC/PA, EMERALD MUTUAL FUND ADVISERS TRUST, FMR LLC, and Cormorant Asset Management, LP.
This page lists
52
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.